A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
β Scribed by Chun-Tao Wai; Joel K. Greenson; Robert J. Fontana; John D. Kalbfleisch; Jorge A. Marrero; Hari S. Conjeevaram; Anna S.-F. Lok
- Book ID
- 111722347
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 144 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Liver biopsy remains the gold standard in the assessment of severity of liver disease. Noninvasive tests have gained popularity to predict histology in view of the associated risks of biopsy. However, many models include tests not readily available, and there are limited data from patients with HIV/
A model was constructed consisting of clinical and serum variables to discriminate between hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) patients with and without significant fibrosis (stages 2-4 vs. stages 0-1). Consecutive treatment-naive CHB patients who underwent liver biopsy